These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 17980451)

  • 1. Long-term effects of a diet loosely restricting carbohydrates on HbA1c levels, BMI and tapering of sulfonylureas in type 2 diabetes: a 2-year follow-up study.
    Haimoto H; Iwata M; Wakai K; Umegaki H
    Diabetes Res Clin Pract; 2008 Feb; 79(2):350-6. PubMed ID: 17980451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.
    Turner RC; Cull CA; Frighi V; Holman RR
    JAMA; 1999 Jun; 281(21):2005-12. PubMed ID: 10359389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No relationship between carbohydrate intake and effect of acarbose on HbA1c or gastrointestinal symptoms in type 2 diabetic subjects consuming 30-60% of energy from carbohydrate.
    Wolever TM; Chiasson JL; Josse RG; Hunt JA; Palmason C; Rodger NW; Ross SA; Ryan EA; Tan MH
    Diabetes Care; 1998 Oct; 21(10):1612-8. PubMed ID: 9773719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Individualized Meal Replacement Therapy Improves Clinically Relevant Long-Term Glycemic Control in Poorly Controlled Type 2 Diabetes Patients.
    Kempf K; Röhling M; Niedermeier K; Gärtner B; Martin S
    Nutrients; 2018 Aug; 10(8):. PubMed ID: 30081574
    [No Abstract]   [Full Text] [Related]  

  • 5. The Effect of Low-Carbohydrate Diet on Glycemic Control in Patients with Type 2 Diabetes Mellitus.
    Wang LL; Wang Q; Hong Y; Ojo O; Jiang Q; Hou YY; Huang YH; Wang XH
    Nutrients; 2018 May; 10(6):. PubMed ID: 29882884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of a short-term 25% carbohydrate diet on improving glycemic control in type 2 diabetes mellitus.
    Gutierrez M; Akhavan M; Jovanovic L; Peterson CM
    J Am Coll Nutr; 1998 Dec; 17(6):595-600. PubMed ID: 9853539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of a Moderate Carbohydrate-Restricted Diet on DPP-4 Inhibitor Action among Individuals with Type 2 Diabetes Mellitus: A 6-Month Intervention Study.
    Kobayashi M; Miura T; Miura K; Hiroyama N; Akashi K
    J Nutr Sci Vitaminol (Tokyo); 2020; 66(2):114-118. PubMed ID: 32350172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of partial use of formula diet on weight reduction and metabolic variables in obese type 2 diabetic patients--multicenter trial.
    Shirai K; Saiki A; Oikawa S; Teramoto T; Yamada N; Ishibashi S; Tada N; Miyazaki S; Inoue I; Murano S; Sakane N; Satoh-Asahara N; Bujo H; Miyashita Y; Saito Y
    Obes Res Clin Pract; 2013; 7(1):e43-54. PubMed ID: 24331681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvements in glucose metabolism and insulin sensitivity with a low-carbohydrate diet in obese patients with type 2 diabetes.
    Krebs JD; Bell D; Hall R; Parry-Strong A; Docherty PD; Clarke K; Chase JG
    J Am Coll Nutr; 2013; 32(1):11-7. PubMed ID: 24015695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. United Kingdom Prospective Diabetes Study 24: a 6-year, randomized, controlled trial comparing sulfonylurea, insulin, and metformin therapy in patients with newly diagnosed type 2 diabetes that could not be controlled with diet therapy. United Kingdom Prospective Diabetes Study Group.
    Ann Intern Med; 1998 Feb; 128(3):165-75. PubMed ID: 9454524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized controlled trial of 130 g/day low-carbohydrate diet in type 2 diabetes with poor glycemic control.
    Sato J; Kanazawa A; Makita S; Hatae C; Komiya K; Shimizu T; Ikeda F; Tamura Y; Ogihara T; Mita T; Goto H; Uchida T; Miyatsuka T; Takeno K; Shimada S; Ohmura C; Watanabe T; Kobayashi K; Miura Y; Iwaoka M; Hirashima N; Fujitani Y; Watada H
    Clin Nutr; 2017 Aug; 36(4):992-1000. PubMed ID: 27472929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic control and vascular diseases under oral antidiabetic drug versus insulin therapy and/or diet alone during the first year of hemodialysis in type 2 diabetic patients with ESRD.
    Biesenbach G; Bodlaj G; Ebner S; Biesenbach P; Pieringer H
    Int Urol Nephrol; 2011 Dec; 43(4):1155-60. PubMed ID: 20640938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dietary Survey of Japanese Individuals with Type 2 Diabetes Mellitus on a Low-Carbohydrate Diet: An Observational Study.
    Inaba S; Shirai T; Sanada M; Miyashita H; Inoue G; Nagahisa T; Wakana N; Homma K; Fukuyama N; Yamada S
    Nutrients; 2024 May; 16(11):. PubMed ID: 38892591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One-year acarbose treatment raises fasting serum acetate in diabetic patients.
    Wolever TM; Radmard R; Chiasson JL; Hunt JA; Josse RG; Palmason C; Rodger NW; Ross SA; Ryan EA; Tan MH
    Diabet Med; 1995 Feb; 12(2):164-72. PubMed ID: 7743764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The European Exenatide study of long-term exenatide vs. glimepiride for type 2 diabetes: rationale and patient characteristics.
    Kazda C; Gallwitz B; Simó R; Guzmán JR; Kraus P; Nicolay C; Rose L; Schernthaner G
    Diabetes Obes Metab; 2009 Dec; 11(12):1131-7. PubMed ID: 19758357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A carbohydrate-reduced high-protein diet improves HbA
    Skytte MJ; Samkani A; Petersen AD; Thomsen MN; Astrup A; Chabanova E; Frystyk J; Holst JJ; Thomsen HS; Madsbad S; Larsen TM; Haugaard SB; Krarup T
    Diabetologia; 2019 Nov; 62(11):2066-2078. PubMed ID: 31338545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of a Mediterranean-style diet on the need for antihyperglycemic drug therapy in patients with newly diagnosed type 2 diabetes: a randomized trial.
    Esposito K; Maiorino MI; Ciotola M; Di Palo C; Scognamiglio P; Gicchino M; Petrizzo M; Saccomanno F; Beneduce F; Ceriello A; Giugliano D
    Ann Intern Med; 2009 Sep; 151(5):306-14. PubMed ID: 19721018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usage pattern, glycemic improvement, hypoglycemia, and body mass index changes with sulfonylureas in real-life clinical practice: results from OBSTACLE Hypoglycemia Study.
    Kalra S; Deepak MC; Narang P; Singh V; Uvaraj MG; Agrawal N
    Diabetes Technol Ther; 2013 Feb; 15(2):129-35. PubMed ID: 23289432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary, secondary, tertiary, and quaternary treatment with troglitazone in type 2 diabetes mellitus in an outpatient clinical practice.
    Hershon KS; Hershon PM
    Endocr Pract; 2000; 6(1):20-5. PubMed ID: 11419922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rationale, design and baseline characteristics of a 4-year (208-week) phase III trial of empagliflozin, an SGLT2 inhibitor, versus glimepiride as add-on to metformin in patients with type 2 diabetes mellitus with insufficient glycemic control.
    Ridderstråle M; Svaerd R; Zeller C; Kim G; Woerle HJ; Broedl UC;
    Cardiovasc Diabetol; 2013 Sep; 12():129. PubMed ID: 24007456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.